NCT01060592

Brief Summary

Subjects having a gastric band fitted will have the first band adjustment done at surgery. The stoma will be set to 7mm using the EndoFLIP system to measure stoma size. Thereafter, band adjustments will be made using an adjustment chart, created at surgery, which shows stoma size versus band fill, to make adjustments in the normal follow-up visits. It is hypothesized that an early adjustment at surgery will promote earlier weight loss, and result in fewer band adjustments being required in the first year after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at below P25 for phase_2 obesity

Timeline
Completed

Started Oct 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 2, 2010

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

April 4, 2013

Completed
Last Updated

April 8, 2013

Status Verified

April 1, 2013

Enrollment Period

1.2 years

First QC Date

January 30, 2010

Results QC Date

February 20, 2013

Last Update Submit

April 4, 2013

Conditions

Keywords

Gastric BandLapBandBariatric Surgery

Outcome Measures

Primary Outcomes (4)

  • %Excess Weight Loss 4-6 Weeks After Surgery (Large and Small Bands)

    4-6 weeks post surgery

  • %Excess Weight Loss 4-6 Weeks After Surgery (Small Bands Only)

    4-6 weeks post surgery

  • % Excess Weight Loss 12 Months After Surgery (Large and Small Bands)

    12m post surgery

  • % Excess Weight Loss 12 Months After Surgery (Small Bands Only)

    12m post surgery

Secondary Outcomes (1)

  • Number of Band Adjustments Required in the First Year After Surgery

    12 months

Study Arms (2)

Stoma Adjustment at Surgery

EXPERIMENTAL

The first band adjustment will be made at surgery versus historical controls where the adjustment is not made for 3-4 weeks post-surgery. EndoFLIP device (FDA Device Listing Number : D091203)will be used to make the adjustment.

Device: EndoFLIP device (FDA Device Listing Number : D091203)

Historic

NO INTERVENTION

Weight loss profile over time for 50 patients in the first 12 months after surgery as derived from historic control records. Band adjustments are made in a heuristic fashion during the year after surgery using the experience of surgeon alone

Interventions

The EndoFLIP balloon catheter will be introduced to the band and used to permit the band stoma size to be adjusted to 7mm.

Stoma Adjustment at Surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing gastric band surgery
  • Over 18 years of age

You may not qualify if:

  • Actively bleeding varices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Specialty Surgery of Fort Worth

Hurst, Texas, 76054, United States

Location

Related Publications (1)

  • Snow RG, O'Dea J. Does Intraoperative Gastric Band Adjustment to a Targeted Stoma Size Improve Weight Loss? One-year Results of a Feasibility Trial Bariatric Times. 2012;9(1):10-12.

    RESULT

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
John O'Dea PhD
Organization
Crospon

Study Officials

  • Robert G Snow, DO FACOS

    AIGB

    PRINCIPAL INVESTIGATOR
  • John O'Dea, PhD

    Crospon

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2010

First Posted

February 2, 2010

Study Start

October 1, 2009

Primary Completion

December 1, 2010

Study Completion

March 1, 2011

Last Updated

April 8, 2013

Results First Posted

April 4, 2013

Record last verified: 2013-04

Locations